TransMedics (TMDX) Cash from Operations Growth (1y) (2019 - 2026)
TransMedics (TMDX) Cash from Operations Growth (1y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.43 Bn | 193.83 Bn | 7.27 Bn | 21.54% |
| 2 | Stryker | 126.52 Bn | 123.04 Bn | 4.50 Bn | 13.50% |
| 3 | Medtronic | 118.76 Bn | 109.54 Bn | 6.41 Bn | 1.78% |
| 4 | Boston Scientific | 73.25 Bn | 72.71 Bn | 3.85 Bn | 14.62% |
| 5 | Edwards Lifesciences | 52.20 Bn | 47.95 Bn | 1.35 Bn | 124.64% |
| 6 | Dexcom | 34.51 Bn | 32.56 Bn | 830.00 Mn | -11.16% |
| 7 | GE HealthCare Technologies | 33.75 Bn | 31.65 Bn | 2.18 Bn | 78.72% |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | -0.23% |
| 9 | Steris | 23.09 Bn | 22.61 Bn | 684.20 Mn | -12.60% |
| 10 | TransMedics | 3.18 Bn | 2.70 Bn | 113.20 Mn | -81.11% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -81.11% |
| Mar 31, 2026 | 959.30% |
| Dec 31, 2025 | 75.52% |
| Sep 30, 2025 | 914.63% |
| Jun 30, 2025 | 256.21% |
| Mar 31, 2025 | 16.89% |
| Dec 31, 2024 | 136.79% |
| Sep 30, 2024 | 199.84% |
| Jun 30, 2024 | 543.18% |
| Mar 31, 2024 | 60.34% |
| Dec 31, 2023 | 305.80% |
| Sep 30, 2023 | 51.91% |
| Jun 30, 2023 | 36.19% |
| Mar 31, 2023 | 52.94% |
| Dec 31, 2022 | 39.31% |
| Sep 30, 2022 | -52.75% |
| Jun 30, 2022 | -64.27% |
| Mar 31, 2022 | -151.11% |
| Dec 31, 2021 | 6.86% |
| Sep 30, 2021 | -45.82% |